工业水过程化学品

Search documents
富淼科技: 江苏富淼科技股份有限公司关于持股5%以上股东协议转让股份暨权益变动、自愿披露签订战略合作协议的公告
Zheng Quan Zhi Xing· 2025-07-17 11:11
Summary of Key Points Core Viewpoint The announcement details a significant equity transfer involving Jiangsu Fumiao Technology Co., Ltd., where a major shareholder, Feixiang Co., is transferring 6,107,600 shares, representing 5% of the company's total equity, to Shanghai Gengrui at a price of 16.38 yuan per share. Additionally, a strategic cooperation agreement has been signed with Xinhu Woolen Textile Co., focusing on wastewater treatment technology in the textile dyeing industry. Group 1: Equity Transfer Details - Feixiang Co. will transfer 6,107,600 unrestricted shares to Shanghai Gengrui at a price of 16.38 yuan per share, which is 80% of the closing price on the trading day before the agreement [1][2][6] - The transfer will not trigger a mandatory tender offer and will not change the controlling shareholder or actual controller of the company [2][3] - After the transfer, Feixiang Co. will hold 16,710,710 shares, representing 13.68% of the total equity [3][11] Group 2: Strategic Cooperation Agreement - A strategic cooperation agreement was signed between Jiangsu Fumiao Technology and Xinhu Woolen Textile Co. to collaborate on wastewater treatment technology in the textile dyeing industry [5][8] - The agreement aims to leverage Fumiao's expertise in industrial water treatment to assist Xinhu in meeting environmental compliance costs [8][12] - The cooperation will focus on developing efficient, low-cost wastewater treatment and resource recovery technologies, including establishing a joint laboratory [9][10] Group 3: Financial and Operational Implications - The total transfer price for the shares is approximately 100 million yuan, with payment structured in two installments [6][7] - The strategic cooperation is expected to enhance Fumiao's market presence and brand influence in the textile industry, although it will not significantly impact the company's 2025 financial performance [12][13] - The agreement does not require board or shareholder approval and is a framework for future collaboration, indicating potential uncertainties in execution [5][12]